Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study

Parvizi, 2009, Peri prosthetic infection due to resistant staphylococci: serious problems on the horizon, Clin Orthop Relat Res, 467, 1732, 10.1007/s11999-009-0857-z Kilgus, 2002, Results of peri prosthetic hip and knee infections caused by resistant bacteria, Clin Orthop Relat Res, 404, 116, 10.1097/00003086-200211000-00021 Peersman, 2001, Infection in total knee replacement: a retrospective review of 6489 total knee replacements, Clin Orthop Relat Res, 392, 15, 10.1097/00003086-200111000-00003 Galdbart, 1999, Phenotypic and genomic variation among Staphylococcus epidermidis strains infecting joint prostheses, J Clin Microbiol, 37, 1306, 10.1128/JCM.37.5.1306-1312.1999 Singh, 2009, Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study, J Med Microbiol, 58, 1067, 10.1099/jmm.0.009720-0 Landersdorfer, 2009, Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations, Clin Pharmacokinet, 48, 89, 10.2165/00003088-200948020-00002 Vuagnat, 2004, High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion, J Clin Pharm Ther, 29, 351, 10.1111/j.1365-2710.2004.00572.x Bernard, 1997, Efficacy and safety of vancomycin constant-rate infusion in the treatment of chronic Gram-positive bone and joint infections, Clin Microbiol Infect, 3, 440, 10.1111/j.1469-0691.1997.tb00280.x Desplaces, 1997, Vancomycine en perfusion continue et infections ostéo-articulaires à staphylocoques multirésistants, Méd Mal Infect, 27, 969, 10.1016/S0399-077X(97)80199-0 Liu, 2011, Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary, Clin Infect Dis, 52, 285, 10.1093/cid/cir034 Rybak, 2009, Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists, Clin Infect Dis, 49, 325, 10.1086/600877 Cremniter, 2010, Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative staphylococci isolated from orthopedic-device-associated infections, J Clin Microbiol, 48, 1428, 10.1128/JCM.02098-09 Norden, 1988, Lessons learned from animal models of osteomyelitis, Rev Infect Dis, 10, 103, 10.1093/clinids/10.1.103 Massias, 1992, Penetration of vancomycin in uninfected sternal bone, Antimicrob Agents Chemother, 36, 2539, 10.1128/AAC.36.11.2539 Tsukayama, 1996, Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections, J Bone Joint Surg Am, 78, 512, 10.2106/00004623-199604000-00005 Zeller, 2007, Propionibacterium acnes: an agent of prosthetic joint infection and colonization, J Infect, 55, 119, 10.1016/j.jinf.2007.02.006 Somme, 2003, Valeur de la ponction systématique pour le diagnostic d'infection avant intervention sur une prothèse de hanche, Joint Bone Spine, 70, 1070 Somme, 2010, Continuous clindamycin infusion, an innovative approach to treating bone and joint infections, Antimicrob Agents Chemother, 54, 88, 10.1128/AAC.01081-09 Shen, 2011, Nephrotoxicity of vancomycin in patients with methicillin-resistant Staphylococcus aureus bacteraemia, Nephrology (Carlton), 16, 697, 10.1111/j.1440-1797.2011.01488.x Murugan, 2011, Acute kidney injury: what's the prognosis?, Nat Rev Nephrol, 7, 209, 10.1038/nrneph.2011.13 Dripps, 1961, The role of anaesthesia in surgical mortality, JAMA, 178, 261, 10.1001/jama.1961.03040420001001 Senneville, 2011, Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus., Clin Infect Dis, 53, 334, 10.1093/cid/cir402 Nilsson, 1999, Heterotopic bone formation after joint replacement, Curr Opin Rheumatol, 11, 127, 10.1097/00002281-199903000-00008 Bellomo, 2004, Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care, 8, 204, 10.1186/cc2872 Zimmerli, 2004, Prosthetic-joint infections, N Engl J Med, 351, 1645, 10.1056/NEJMra040181 Natoli, 2009, Characterization of coagulase-negative staphylococcal isolates from blood with reduced susceptibility to glycopeptides and therapeutic options, BMC Infect Dis, 9, 83, 10.1186/1471-2334-9-83 Stefansdottir, 2009, Microbiology of the infected knee arthroplasty: report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases, Scand J Infect Dis, 41, 831, 10.3109/00365540903186207 Dombrowski, 2008, Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections, J Infect, 57, 110, 10.1016/j.jinf.2008.04.003 Kullar, 2011, Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines-suggested targets, Clin Infect Dis, 52, 975, 10.1093/cid/cir124 Lodise, 2008, Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity, Antimicrob Agents Chemother, 52, 1330, 10.1128/AAC.01602-07 Lodise, 2009, Relationship between initial vancomycin concentration–time profile and nephrotoxicity among hospitalized patients, Clin Infect Dis, 49, 507, 10.1086/600884 Ingram, 2009, Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy, Int J Antimicrob Agents, 34, 570, 10.1016/j.ijantimicag.2009.07.011